Aprepitant sensitizes acute myeloid leukemia cells to the cytotoxic effects of cytosine arabinoside in vitro and in vivo
H Wu, X Cheng, F Huang, G Shao, Y Meng… - Drug Design …, 2020 - Taylor & Francis
… However, the combination of Ara-C and Aprepitant markedly enhanced cell cycle arrest
with the G0/G1 phase distribution of 76.02 ± 1.51% comparing with Ara-C group or Aprepitant …
with the G0/G1 phase distribution of 76.02 ± 1.51% comparing with Ara-C group or Aprepitant …